abstract |
The invention relates to a pharmaceutical combination, which is intended for the treatment of a malignant tumor. The composition contains an antibody that specifically recognizes CD38 and cytarabine. In addition, a method for the treatment of a malignant tumor, which includes the introduction of the specified combination to an individual in need. The invention can be effectively used in the treatment of malignant tumors. |